QoL · men with lower urinary tract symptoms secondary to benign prostatic obstruction
1 finding from 1 review
Adverse events · men with lower urinary tract symptoms secondary to benign prostatic obstruction
Combination therapy showed no clear difference in adverse events compared with alpha‐blockers (low certainty).
1 finding from 1 review
AUR · men with lower urinary tract symptoms secondary to benign prostatic obstruction
Combination therapy showed no clear difference in AUR compared with alpha‐blockers (low certainty).
1 finding from 1 review
Symptom score for LUTS · men with lower urinary tract symptoms secondary to benign prostatic obstruction
1 finding from 1 review
Response rate · men with lower urinary tract symptoms secondary to benign prostatic obstruction
It is very uncertain whether physical activity changes response rate compared with alpha‐blockers (very low certainty).
1 finding from 1 review
Withdrawals due to adverse events · men with lower urinary tract symptoms secondary to benign prostatic obstruction
Physical activity showed no clear difference in withdrawal due to adverse events compared with alpha‐blockers (low certainty).
1 finding from 1 review
IPSS‐total score
1 finding from 1 review
BPHII score
1 finding from 1 review
Adverse events
PDEI showed no clear difference in adverse events compared with alpha‐blockers (low certainty).
1 finding from 1 review
IPSS‐total score
1 finding from 1 review
BPHII score
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse effects
PDEI plus alpha‐blocker probably leads to higher adverse effects compared with alpha‐blockers alone (moderate certainty).
1 finding from 1 review
Urologic symptom scores · men with lower urinary tract symptoms secondary to benign prostatic obstruction
1 finding from 1 review
Urologic symptom scores · men with lower urinary tract symptoms secondary to benign prostatic obstruction
1 finding from 1 review
QoL · men with lower urinary tract symptoms secondary to benign prostatic obstruction
1 finding from 1 review
Adverse events · men with lower urinary tract symptoms secondary to benign prostatic obstruction
Combination therapy showed no clear difference in adverse events compared with anticholinergics (moderate certainty).
1 finding from 1 review
AUR · men with lower urinary tract symptoms secondary to benign prostatic obstruction
Combination therapy showed no clear difference in AUR compared with anticholinergics (low certainty).
1 finding from 1 review
Surgical intervention – not reported · men with lower urinary tract symptoms secondary to benign prostatic obstruction
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
QoL · men with lower urinary tract symptoms secondary to benign prostatic obstruction
1 finding from 1 review
Adverse events · men with lower urinary tract symptoms secondary to benign prostatic obstruction
Combination therapy probably leads to higher adverse events compared with placebo (moderate certainty).
1 finding from 1 review